SHIM compared with VRCA: revenue, margins and what each company keeps, and the suppliers and customers both name

SHIMShimmick Corp

Mkt capRevenueRevenue

VRCAVerrica Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

SHIMShimmick Corp

VRCAVerrica Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

SHIM: latest quarter is a loss; flow not drawable. VRCA: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only SHIM 0

None

Shared 0

No disclosed counterparties: SHIM.

Only VRCA 1

—Lytix BioPharma ASunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

SHIM, solidVRCA, dashed

SHIMShimmick Corp

2.54▼−1.17%· post 2.54

Mkt cap$103.8MRevenue$142MQ3 FY26Revenue$633MFY23

VRCAVerrica Pharmaceuticals Inc.

3.30▼−3.51%· post 3.40

ClosedOct 30 '26

Mkt cap$57.5MRevenue$6MQ2 FY26Revenue$36MFY25

Compare

ClosedOct 30 '26

SHIMShimmick Corp

VRCAVerrica Pharmaceuticals Inc.

2.54▼−1.17%post 2.54

Price

3.30▼−3.51%post 3.40

$103.8M

Mkt cap

$57.5M

Q3 FY26$142M

Revenue

$6MQ2 FY26

FY23$633M

Revenue

$36MFY25

SHIM2.54▼−1.17%vsVRCA3.30▼−3.51%ClosedOct 30 '26